The production of monocyte-derived KCs in NASH patients is a response to increased embryonically derived macrophage death and aims to maintain the population of KCs (Seidman et al., 2020; Daemen et al., 2021). This evidence concerns the gene TBCE and metabolic dysfunction-associated steatohepatitis.